Carexiaa Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.17 M
as on 16-11-2024
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.00 M
as on 16-11-2024
- Revenue 48.33%
(FY 2023)
- Profit 60.62%
(FY 2023)
- Ebitda 70.70%
(FY 2023)
- Net Worth -195.69%
(FY 2023)
- Total Assets 22.14%
(FY 2023)
About Carexiaa Healthcare
The Corporate was formerly known as Carexia Healthcare Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.17 M.
The company currently has active open charges totaling ₹9.00 M.
Makarand Kulkarni, Jayant Shirode, and Rajashri Shirode serve as directors at the Company.
- CIN/LLPIN
U74999MH2019PTC324198
- Company No.
324198
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Carexiaa Healthcare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayant Shirode  | Managing Director | 16-Apr-2019 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Makarand Kulkarni | Director | 16-Apr-2019 | Current |
| Rajashri Shirode | Additional Director | 31-Jan-2024 | Current |
Financial Performance of Carexiaa Healthcare.
Carexiaa Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.33% increase. The company also saw a substantial improvement in profitability, with a 60.62% increase in profit. The company's net worth observed a substantial decline by a decrease of 195.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Carexiaa Healthcare?
In 2023, Carexiaa Healthcare had a promoter holding of 87.49% and a public holding of 12.51%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 01 Feb 2021 | ₹9.00 M | Open |
How Many Employees Work at Carexiaa Healthcare?
Carexiaa Healthcare has a workforce of 49 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Carexiaa Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Carexiaa Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
